therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications. Asian J Androl 2012;14:222–225.
25Santosa S, Khosla S, McCready LK, Jensen MD: Effects of estrogen and testosterone on resting energy expenditure in older men. Obesity (Silver Spring) 2010;18:2392–2394.
26Chao J, Rubinow KB, Kratz M, Amory JK, Matsumoto AM, Page ST: Short-term estrogen withdrawal increases adiposity in healthy men. J Clin Endocrinol Metab 2016;101:3724–3731.
27Vandewalle S, Taes Y, Fiers T, Toye K, Van Caenegem E, Roggen I, et al: Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents. J Clin Endocrinol Metab 2014;99:E1272–E1282.
28Vandewalle S, Taes Y, Fiers T, Van Helvoirt M, Debode P, Herregods N, et al: Sex steroids in relation to sexual and skeletal maturation in obese male adolescents. J Clin Endocrinol Metab 2014;99:2977–2985.
29Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y: Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000;141:649–656.
30Blouin K, Boivin A, Tchernof A: Androgens and body fat distribution. J Steroid Biochem Mol Biol 2008;108:272–280.
31Blouin K, Nadeau M, Perreault M, Veilleux A, Drolet R, Marceau P, et al: Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) 2010;72:176–188.
32Xu X, De Pergola G, Björntorp P: The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990;126:1229–1234.
33Dubois V, Laurent MR, Jardi F, Antonio L, Lemaire K, Goyvaerts L, et al: Androgen deficiency exacerbates high-fat diet-induced metabolic alterations in male mice. Endocrinology 2016;157:648–665.
34O’Connell MD, Wu FC: Androgen effects on skeletal muscle: implications for the development and management of frailty. Asian J Androl 2014;16:203–212.
35Chusyd DE, Wang D, Huffman DM, Nagy TR: Relationships between rodent white adipose fat pads and human white adipose fat depots. Front Nutr 2016;3:10.
36Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y: Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 1998;274(6 Pt 1):C1645–C1652.
37Lacasa D, Garcia E, Henriot D, Agli B, Giudicelli Y: Site-related specificities of the control by androgenic status of adipogenesis and mitogen-activated protein kinase cascade/c-fos signaling pathways in rat preadipocytes. Endocrinology 1997;138:3181–3186.
38James RG, Krakower GR, Kissebah AH: Influence of androgenicity on adipocytes and precursor cells in female rats. Obes Res 1996;4:463–470.
39Elbers JM, de Jong S, Teerlink T, Asscheman H, Seidell JC, Gooren LJ: Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism 1999;48:1371–1377.
40Rodriguez-Cuenca S, Monjo M, Proenza AM, Roca P: Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am J Physiol Endocrinol Metab 2005;288:E200–E207.
41Veilleux A, Côté JA, Blouin K, Nadeau M, Pelletier M, Marceau P, et al: Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes. Am J Physiol Endocrinol Metab 2012;302:E941–E949.
42Beilin J, Ball EM, Favaloro JM, Zajac JD: Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000;25:85–96.
43Pausova Z, Abrahamowicz M, Mahboubi A, Syme C, Leonard GT, Perron M, et al: Functional variation in the androgen-receptor gene is associated with visceral adiposity and blood pressure in male adolescents. Hypertension 2010;55:706–714.
44De Naeyer H, Bogaert V, De Spaey A, Roef G, Vandewalle S, Derave W, et al: Genetic variations in the androgen receptor are associated with steroid concentrations and anthropometrics but not with muscle mass in healthy young men. PLoS One 2014;9:e86235.
45Lapauw B, Goemaere S, Crabbe P, Kaufman JM, Ruige JB: Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? Eur J Endocrinol 2007;156:395–401.
46Nielsen TL, Hagen C, Wraae K, Bathum L, Larsen R, Brixen K, et al: The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study. Eur J Endocrinol 2010;162:795–804.
47Ibrahim MM: Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010;11:11–18.
48Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W: Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J Endocrinol 2004;183:331–342.
49O’Reilly MW, Kempegowda P, Walsh M, Taylor AE, Manolopoulos KN, Allwood JW, et al: AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017;102:3327–3339.
50Hazlehurst JM, Oprescu AI, Nikolaou N, Di Guida R, Grinbergs AE, Davies NP, et al: Dual-5α-reductase inhibition promotes hepatic lipid accumulation in man. J Clin Endocrinol Metab 2016;101:103–113.
51Giagulli VA, De Pergola G, Giorgino F, Cignarelli M, Abbaticchio G, Vermeulen A, et al: Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women. Clin Endocrinol (Oxf) 1992;36:553–558.
52Fassnacht M, Schlenz N, Schneider